For Novavax, Building Trust Was Key To Improving Diversity
Company Took Lead In Native American Vaccine Study Enrollment
Novavax’s Lisa Dunkle talked to Scrip about the time and effort that went into building trust among Native American communities to encourage participation in its COVID-19 vaccine study.
You may also be interested in...
JAMA reports on the COVID-19 Prevention Network’s efforts. Also, Inhibikase said the US FDA lifted a hold on its drug for Parkinson’s disease, while Astellas Pharma said the agency lifted a clinical hold on its gene therapy for Pompe disease. And Trefoil, Theriva Biologics and Nektar initiated new trials.
Data on minority groups were frequently underreported, and in many cases numbers have not improved with time, according to the study by Tufts CSDD.
The study, by Tufts CSDD, also found that data on minority groups were frequently underreported, and in many cases numbers have not improved with time.